Page 1 | Search Results | The Hematologist | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Articles

Clonal Hematopoiesis in Nonhuman Primates: Harnessing Shared Evolution to Model Clonal Selection in Human Disease

Jozal W. Moore, MD, Kristen M. O’Dwyer, MD

The Hematologist (2023) 20 (1)

https://doi.org/10.1182/hem.V20.1.202312

Published: 2023

Articles

CDX2/UBTF Acute Lymphoblastic Leukemia: Subtype Discovery and Clinical Implications

Kristen M. O’Dwyer, MD

The Hematologist (2022) 19 (5)

https://doi.org/10.1182/hem.V19.5.2022515

Published: 2022

Articles

Rituximab in B-ALL: How Much and for Whom?

Kristen M. O'Dwyer, MD

The Hematologist (2022) 19 (4)

https://doi.org/10.1182/hem.V19.4.2022414

Published: 2022

Articles

In Response to Back to HiDAC

Yaddanapudi Ravindranath, MBBS, Kristen M. O'Dwyer, MD

The Hematologist (2022) 19 (4)

https://doi.org/10.1182/hem.V19.4.2022417

Published: 2022

Articles

A Chemotherapy-free Regimen for Older Adults and Relapsed or Refractory B-ALL

Kristen M. O’Dwyer, MD

The Hematologist (2022) 19 (3)

https://doi.org/10.1182/hem.V19.3.2022316

Published: 2022

Articles

When Is a Needle Not Enough? Exploring the Limits of Cytology and Core Biopsies

Kristen M. O'Dwyer, MD, Richard Burack, MD, PhD

The Hematologist (2022) 19 (2)

https://doi.org/10.1182/hem.V19.2.2022217

Published: 2022

Articles

Back to HiDAC: Administering the Optimal Treatment for Children With Down Syndrome and Acute Myeloid Leukemia

Kristen M. O’Dwyer, MD

The Hematologist (2022) 19 (2)

https://doi.org/10.1182/hem.V19.2.2022213

Published: 2022

Articles

From Myth to Reality: Achieving a Second Remission in Acute Lymphoblastic Leukemia

Kristen M. O'Dwyer, MD

The Hematologist (2022) 19 (1)

https://doi.org/10.1182/hem.V19.1.2022110

Published: 2022

Articles

TaLLy-ing Up Prognostic Features for T-Lymphoblastic Lymphoma

Kim Seymour, MD, Kristen M. O’Dwyer, MD

The Hematologist (2021) 18 (6)

https://doi.org/10.1182/hem.V18.6.2021613

Published: 2021

Articles

The Toll of Prophylaxis: Cytomegalovirus Infection in the Haploidentical Donor and Post-transplant Cyclophosphamide Era

Tate Feeney, PharmD, BCOP, Kristen M. O’Dwyer, MD

The Hematologist (2021) 18 (5)

https://doi.org/10.1182/hem.V18.5.2021514

Published: 2021

Articles

The Rules of the Road Have Changed: What's the Best Route to Curing ALL?

Emily K. Curran, MD, Kristen M. O'Dwyer, MD

The Hematologist (2021) 18 (4)

https://doi.org/10.1182/hem.V18.4.202143

Published: 2021

Articles

New Hope for Antibody-based Immunotherapy for AML: Will the DART Hit the Bullseye?

Kristen M. O'Dwyer, MD, Nancy Torres, MD

The Hematologist (2021) 18 (3)

Published: 2021

Articles

Pursuing a Chemotherapy-free Regimen in Philadelphia Chromosome-Positive ALL

Kristen M. O’Dwyer, MD

The Hematologist (2021) 18 (2)

Published: 2021

Articles

T-Cell Battle Royale: Chimeric Antigen Receptor T-cells for the Treatment of T-lineage Acute Lymphoblastic Leukemia

Jozal W. Moore, MD, Kristen M. O’Dwyer, MD

The Hematologist (2020) 18 (1)

Published: 2020

Articles

Selection of Preparative Regimens for Haploidentical Bone Marrow Transplantation With Post-transplant Cyclophosphamide: Age Is Not Just a Number

Kristen M. O’Dwyer, MD

The Hematologist (2020) 17 (6)

Published: 2020

Articles

Allogeneic HSCT After PD-1 Blockade: Has Post-transplant Cyclophosphamide Rendered Checkpoint Inhibition a Safe Bridge to Allogeneic Stem Cell Transplantation?

Ash B. Alpert, MD, MFA, Kristen M. O'Dwyer, MD

The Hematologist (2020) 17 (4)

https://doi.org/10.1182/hem.V17.4.12884901916

Published: 2020

Articles

T-cell Lymphoblastic Leukemia: What Are the Prospects for Novel Immunotherapy?

Kristen M. O'Dwyer, MD

The Hematologist (2020) 17 (3)

https://doi.org/10.1182/hem.V17.3.10366

Published: 2020

Articles

The MEDALIST Trial: Are We on the Podium for Lower-Risk MDS?

Kristen M. O'Dwyer, MD

The Hematologist (2020) 17 (2)

https://doi.org/10.1182/hem.V17.2.10281

Published: 2020

Articles

Venetoclax Regimens in Acute Myeloid Leukemia: Do We Have the Answers?

Kristen M. O'Dwyer, MD, Eric Huselton, MD

The Hematologist (2020) 17 (1)

https://doi.org/10.1182/hem.V17.1.10178

Published: 2020

Articles

Outfoxing OXPHOS: Amino Acid Metabolism and the Leukemia Stem Cell

Kristen M. O'Dwyer, MD

The Hematologist (2019) 16 (6)

https://doi.org/10.1182/hem.V16.6.9976

Published: 2019

NARROW

Clonal Hematopoiesis in Nonhuman Primates: Harnessing Shared Evolution to Model Clonal Selection in Human Disease

CDX2/UBTF Acute Lymphoblastic Leukemia: Subtype Discovery and Clinical Implications

Rituximab in B-ALL: How Much and for Whom?

In Response to Back to HiDAC

A Chemotherapy-free Regimen for Older Adults and Relapsed or Refractory B-ALL

When Is a Needle Not Enough? Exploring the Limits of Cytology and Core Biopsies

Back to HiDAC: Administering the Optimal Treatment for Children With Down Syndrome and Acute Myeloid Leukemia

From Myth to Reality: Achieving a Second Remission in Acute Lymphoblastic Leukemia

TaLLy-ing Up Prognostic Features for T-Lymphoblastic Lymphoma

The Toll of Prophylaxis: Cytomegalovirus Infection in the Haploidentical Donor and Post-transplant Cyclophosphamide Era

The Rules of the Road Have Changed: What's the Best Route to Curing ALL?

New Hope for Antibody-based Immunotherapy for AML: Will the DART Hit the Bullseye?

Pursuing a Chemotherapy-free Regimen in Philadelphia Chromosome-Positive ALL

T-Cell Battle Royale: Chimeric Antigen Receptor T-cells for the Treatment of T-lineage Acute Lymphoblastic Leukemia

Selection of Preparative Regimens for Haploidentical Bone Marrow Transplantation With Post-transplant Cyclophosphamide: Age Is Not Just a Number

Allogeneic HSCT After PD-1 Blockade: Has Post-transplant Cyclophosphamide Rendered Checkpoint Inhibition a Safe Bridge to Allogeneic Stem Cell Transplantation?

T-cell Lymphoblastic Leukemia: What Are the Prospects for Novel Immunotherapy?

The MEDALIST Trial: Are We on the Podium for Lower-Risk MDS?

Venetoclax Regimens in Acute Myeloid Leukemia: Do We Have the Answers?

Outfoxing OXPHOS: Amino Acid Metabolism and the Leukemia Stem Cell

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only